Bioventus (BVS) Shares Outstanding (Entity) (2021 - 2026)
Bioventus (BVS) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 1.73 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 383.57 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 576.60 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 377.40 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 451.69 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 977.43 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 97.50 Mn |
| 10 | Bioventus | 982.75 Mn | 953.29 Mn | 105.67 Mn | 84.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 68.21 Mn |
| Mar 28, 2026 | 67.64 Mn |
| Dec 31, 2025 | 67.10 Mn |
| Sep 27, 2025 | 66.97 Mn |
| Jun 28, 2025 | 66.89 Mn |
| Mar 29, 2025 | 66.23 Mn |
| Dec 31, 2024 | 65.76 Mn |
| Sep 28, 2024 | 65.34 Mn |
| Jun 29, 2024 | 65.17 Mn |
| Mar 30, 2024 | 63.67 Mn |
| Dec 31, 2023 | 63.27 Mn |
| Sep 30, 2023 | 62.96 Mn |
| Jul 1, 2023 | 62.80 Mn |
| Apr 1, 2023 | 62.51 Mn |
| Dec 31, 2022 | 62.06 Mn |
| Oct 1, 2022 | 61.78 Mn |
| Jul 2, 2022 | 61.66 Mn |
| Apr 2, 2022 | 61.36 Mn |
| Dec 31, 2021 | 45.47 Mn |
| Oct 2, 2021 | 41.10 Mn |